找回密碼
 To register

QQ登錄

只需一步,快速開(kāi)始

掃一掃,訪問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: Antitrust in Pharmaceutical Markets & Geographical Rules of Origin; Pierre Kobel,Pranvera K?llezi,Bruce Kilpatrick Book 2017 The Editor(s)

[復(fù)制鏈接]
樓主: estradiol
11#
發(fā)表于 2025-3-23 11:39:17 | 只看該作者
12#
發(fā)表于 2025-3-23 17:09:01 | 只看該作者
Ukraines no specific treatment of pharmaceutical products under the Ukrainian competition law. The law “On Protection of Economic Competition” (hereafter “Competition Law”) contains the main provisions regarding the protection of competition. In particular, the key provisions of Competition Law dealing wit
13#
發(fā)表于 2025-3-23 19:50:36 | 只看該作者
14#
發(fā)表于 2025-3-24 00:17:38 | 只看該作者
15#
發(fā)表于 2025-3-24 05:21:24 | 只看該作者
Wolfgang Kersten,Kirsten A. Schr?derral rules. New amendments of both Acts are currently in the pipeline, following European Directive 2014/104 on antitrust damages actions, which has to be implemented in the legal systems of all EU Member States by December 27, 2016.
16#
發(fā)表于 2025-3-24 08:03:21 | 只看該作者
E-Business in Produktionsnetzwerkention law and (iv) whether there is shared practice on budgetary and other public interest considerations. Particular attention is paid to market definition in de pharmaceutical sector, parallel trade and generic entry.
17#
發(fā)表于 2025-3-24 11:36:42 | 只看該作者
Wissensmanagement im E-Commercevant competition law regulations, are directly applicable in the Czech Republic and therefore play a key role as regards the protection of competition in the Czech Republic. Nevertheless, this report focuses on national competition law.
18#
發(fā)表于 2025-3-24 15:53:08 | 只看該作者
https://doi.org/10.1007/978-3-642-56831-2h infringements in the pharmaceutical sector relate to anticompetitive concerted actions (Article 6 of Competition Law), concerted actions on supply and use of goods (Article 8 of Competition Law), and abuse of dominance (Article 13 of Competition Law).
19#
發(fā)表于 2025-3-24 22:11:57 | 只看該作者
Electronic Business und Multimediaf enforcement activity in this sector in the United States or, more recently, in the European Union. The Competition Commission has notably not had to struggle with reverse payment settlements and other issues at the crossroad of intellectual property and competition law.
20#
發(fā)表于 2025-3-25 00:40:11 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛(ài)論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-8 05:08
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
长丰县| 皋兰县| 江油市| 博乐市| 闽侯县| 景谷| 洛隆县| 泸州市| 襄垣县| 东光县| 梅州市| 湾仔区| 保德县| 秦皇岛市| 济南市| 永登县| 城市| 巴彦淖尔市| 陵水| 循化| 汕尾市| 乐清市| 井研县| 亚东县| 祁阳县| 峡江县| 项城市| 达尔| 石嘴山市| 井研县| 泰顺县| 霞浦县| 乐安县| 阜城县| 阳城县| 岐山县| 秦安县| 盖州市| 永定县| 紫阳县| 阜宁县|